Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats
British Journal of Pharmacology2020Vol. 178(1), pp. 203–216
Citations Over TimeTop 10% of 2020 papers
Jiang Qian, C. Liu, Shiyun Liu, Wenju Lu, Yi Li, Xiaoyun Luo, Ran Ma, Chenting Zhang, Hạixia Chen, Yuqin Chen, Zizhou Zhang, Cheng Hong, Wenliang Guo, Tao Wang, Kai Yang, Jian Wang
Abstract
This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc.
Related Papers
- → Proapoptotic Bid is required for pulmonary fibrosis(2006)118 cited
- → Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis(2008)12 cited
- Effect of peimisine on pulmonary interstitial fibrosis induced by bleomycin in mouse pulmonary fibrosis.(2024)
- Research on intervention effect of breviscapme injection on rats with pulmonary fibrosis(2009)
- Effects of epigallocatechin gallate on rats with pulmonary fibrosis induced by bleomycin(2009)